We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£109.06
Springer Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15
Price data last checked 37 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£109 today · cheaper than every other day in the last 2 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 28 days • 28 data points (No recent data available)
Price Distribution
Price distribution over 28 days • 3 price levels
Price Analysis
Most common price: £110 (11 days, 39.3%)
Price range: £109 - £112
Price levels: 3 different prices over 28 days
Description
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 3030098176
- Domain
- Amazon UK
- Release Date
- 02 February 2019
- Listed Since
- 02 February 2019
Barcode
No barcode data available
Similar Products You Might Like
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance: 1 (Resistance to Targeted Anti-Cancer Therapeutics, 1)
Springer
Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)
Academic Press
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
Springer
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
Springer
Molecular Oncology: Underlying Mechanisms and Translational Advancements
Springer
Gene Regulation and Therapeutics for Cancer
CRC Press
Resistance to Molecular Therapies for Hepatocellular Carcinoma: 13 (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
Pharmaceutical Perspectives of Cancer Therapeutics
Springer
Cell Signaling & Molecular Targets in Cancer
Springer
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
Springer
Systems Biology in Cancer Research and Drug Discovery
Springer
Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
Springer
Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy
Academic Press
Current Applications for Overcoming Resistance to Targeted Therapies: 20 (Resistance to Targeted Anti-Cancer Therapeutics, 20)
Springer
Cancer Drug Discovery: Science and History
Springer
Molecular Targets and Strategies in Cancer Prevention
Springer
Cancer Genetics and Therapeutics: Focus on Phytochemicals
Springer
Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)
Springer
Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach
Springer
Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance
Academic Press
The Hippo Signaling Pathway and Cancer
Springer
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
Springer